Market Cap 886.79M
Revenue (ttm) 96.21M
Net Income (ttm) -4.60M
EPS (ttm) N/A
PE Ratio 153.00
Forward PE 175.65
Profit Margin -4.78%
Debt to Equity Ratio 0.01
Volume 439,700
Avg Vol 423,178
Day's Range N/A - N/A
Shares Out 48.30M
Stochastic %K 13%
Beta 1.90
Analysts Strong Sell
Price Target $32.67

Company Profile

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induc...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 425 402 1400
Fax: 425 402 1433
Address:
3303 Monte Villa Parkway, Suite 310, Bothell, United States
StreetwiseReports
StreetwiseReports Mar. 13 at 5:28 PM
Bothell, WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands https://ow.ly/Iw4v50YtzrI BioLife Solutions Inc. ($BLFS:NASDAQ) reported strong 2025 results. The company is now a pure-play cell processing business, expecting double-digit growth driven by expanding cell and gene therapy adoption, according to an H.C. Wainwright & Co. research note.
0 · Reply
GoBigD
GoBigD Mar. 10 at 8:36 PM
$BLFS New 52 week low added more at close today
1 · Reply
GoBigD
GoBigD Mar. 5 at 8:36 PM
$BLFS Ok. I’m in here starting a position.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 5:50 PM
$BLFS RSI: 37.68, MACD: -0.4100 Vol: 0.71, MA20: 22.52, MA50: 23.77 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NorthStarStats
NorthStarStats Mar. 2 at 2:35 AM
For anyone following along, I developed a Python-based statistical scanner to identify stocks with near-term institutional accumulation and upward price momentum. With the news over the weekend; expected weaker outcomes. $BLFS Score: 100, $SNDX Score 100, $CGEN Score 98.00, $DRD Score 98.00, $XYZ Score 98.00
2 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 27 at 7:27 PM
$BLFS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.23 down -11.54% YoY • Reported revenue of $24.76M up 823.25% YoY • BioLife Solutions expects 2026 revenue of $112.5M to $115M, representing 17%-20% growth over 2025. The company anticipates GAAP net income for the full year and continued adjusted EBITDA margin expansion.
0 · Reply
6GodEnergy
6GodEnergy Feb. 27 at 6:22 PM
_@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow it’s completely free and only takes a second 💎 $SSL $IRD $HUDI $BLFS ^[] on watch.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:18 PM
$BLFS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.23 down -11.54% YoY • Reported revenue of $24.76M up 823.25% YoY • BioLife Solutions expects 2026 revenue growth of $112.5M to $115M, representing 17%-20% growth over 2025, with GAAP net income for the full year and continued expansion of adjusted EBITDA margin.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 8:54 PM
$BLFS Current Stock Price: $22.88 Contracts to trade: $25.0 BLFS Mar 20 2026 Call Entry: $0.91 Exit: $1.63 ROI: 79% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
TheTradeXchange
TheTradeXchange Feb. 12 at 1:04 PM
$BLFS BLFS - BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
0 · Reply
Latest News on BLFS
BioLife Looks Strong For Fiscal Year 2026

Mar 6, 2026, 11:08 AM EST - 9 days ago

BioLife Looks Strong For Fiscal Year 2026


BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 9:47 PM EST - 16 days ago

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript


BioLife Solutions, Inc. (BLFS) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:06 PM EST - 4 months ago

BioLife Solutions, Inc. (BLFS) Q3 2025 Earnings Call Transcript


BioLife Solutions Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:03 PM EST - 4 months ago

BioLife Solutions Reports Third Quarter 2025 Financial Results


BioLife: Back To Basics Is Getting Traction (Rating Upgrade)

Oct 1, 2025, 9:43 AM EDT - 5 months ago

BioLife: Back To Basics Is Getting Traction (Rating Upgrade)


BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:22 PM EDT - 7 months ago

BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript


BioLife Solutions Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:03 PM EDT - 7 months ago

BioLife Solutions Reports Second Quarter 2025 Financial Results


BioLife Solutions Makes Strategic Investment in Pluristyx

Jul 28, 2025, 8:05 AM EDT - 8 months ago

BioLife Solutions Makes Strategic Investment in Pluristyx


BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:59 PM EDT - 11 months ago

BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript


BioLife Solutions Updates Earnings Call Information

May 8, 2025, 4:32 PM EDT - 11 months ago

BioLife Solutions Updates Earnings Call Information


BioLife Solutions Reports First Quarter 2025 Financial Results

May 8, 2025, 4:03 PM EDT - 11 months ago

BioLife Solutions Reports First Quarter 2025 Financial Results


BioLife Is Cleaning Ship

Aug 20, 2024, 3:51 PM EDT - 1 year ago

BioLife Is Cleaning Ship


BioLife Solutions: A Complicated Tale

Nov 29, 2023, 3:06 PM EST - 2 years ago

BioLife Solutions: A Complicated Tale


StreetwiseReports
StreetwiseReports Mar. 13 at 5:28 PM
Bothell, WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands https://ow.ly/Iw4v50YtzrI BioLife Solutions Inc. ($BLFS:NASDAQ) reported strong 2025 results. The company is now a pure-play cell processing business, expecting double-digit growth driven by expanding cell and gene therapy adoption, according to an H.C. Wainwright & Co. research note.
0 · Reply
GoBigD
GoBigD Mar. 10 at 8:36 PM
$BLFS New 52 week low added more at close today
1 · Reply
GoBigD
GoBigD Mar. 5 at 8:36 PM
$BLFS Ok. I’m in here starting a position.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 5:50 PM
$BLFS RSI: 37.68, MACD: -0.4100 Vol: 0.71, MA20: 22.52, MA50: 23.77 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NorthStarStats
NorthStarStats Mar. 2 at 2:35 AM
For anyone following along, I developed a Python-based statistical scanner to identify stocks with near-term institutional accumulation and upward price momentum. With the news over the weekend; expected weaker outcomes. $BLFS Score: 100, $SNDX Score 100, $CGEN Score 98.00, $DRD Score 98.00, $XYZ Score 98.00
2 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 27 at 7:27 PM
$BLFS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.23 down -11.54% YoY • Reported revenue of $24.76M up 823.25% YoY • BioLife Solutions expects 2026 revenue of $112.5M to $115M, representing 17%-20% growth over 2025. The company anticipates GAAP net income for the full year and continued adjusted EBITDA margin expansion.
0 · Reply
6GodEnergy
6GodEnergy Feb. 27 at 6:22 PM
_@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow it’s completely free and only takes a second 💎 $SSL $IRD $HUDI $BLFS ^[] on watch.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:18 PM
$BLFS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.23 down -11.54% YoY • Reported revenue of $24.76M up 823.25% YoY • BioLife Solutions expects 2026 revenue growth of $112.5M to $115M, representing 17%-20% growth over 2025, with GAAP net income for the full year and continued expansion of adjusted EBITDA margin.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 8:54 PM
$BLFS Current Stock Price: $22.88 Contracts to trade: $25.0 BLFS Mar 20 2026 Call Entry: $0.91 Exit: $1.63 ROI: 79% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
TheTradeXchange
TheTradeXchange Feb. 12 at 1:04 PM
$BLFS BLFS - BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
0 · Reply
commoncentsinvestor
commoncentsinvestor Feb. 6 at 4:26 PM
$BLFS Best bet for huge gain in 2026 = ABEO.
0 · Reply
MacroBeacon
MacroBeacon Feb. 4 at 2:26 PM
$BLFS is a provider of bioprocess systems and services for the life sciences industry; demand is tied to biopharma manufacturing capacity investments.
0 · Reply
jpad
jpad Jan. 23 at 5:02 PM
$BLFS how far will they push it down this time
0 · Reply
jpad
jpad Jan. 23 at 3:18 PM
$BLFS probably a run back up to $27 or 28 coming Maybe a rally depending on guidance
0 · Reply
jpad
jpad Jan. 23 at 3:16 PM
$BLFS good earnings slightly beat expectations
0 · Reply
Magnanimoustrader
Magnanimoustrader Jan. 13 at 12:31 AM
$BLFS seems like a decent zone to buy... may trade this one again soon
0 · Reply
jpad
jpad Jan. 7 at 7:47 PM
$BLFS same crap. This stock just gets played
0 · Reply
jpad
jpad Jan. 7 at 7:09 PM
$BLFS typical. Never let it go to high
0 · Reply
jpad
jpad Jan. 7 at 9:47 AM
$BLFS nice to see positive after hours Maybe something going on
0 · Reply
jpad
jpad Dec. 31 at 6:16 PM
$BLFS next year over $30
0 · Reply
VentricleV
VentricleV Dec. 27 at 5:17 AM
$BLFS Sentiment increasingly tracks operational truth rather than guidance tone. Competitive advantages must begin to appear in core metrics. Execution consistency is the fastest path to confidence rebuilding. As performance stabilizes, the path forward can strengthen.
0 · Reply
jpad
jpad Dec. 10 at 12:47 PM
$BLFS new year we go over $31
0 · Reply